» Articles » PMID: 31727870

Pulmonary Infarction Due to Paget-Schroetter Syndrome and Nephrotic Syndrome

Overview
Journal Am J Case Rep
Specialty General Medicine
Date 2019 Nov 16
PMID 31727870
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Risk factors for venous thromboembolism can include a combination of genetic, anatomic, and physiologic factors, some of which are modifiable. Patients presenting to the hospital with venous thromboembolism may have multiple risk factors that require testing beyond the initial admission labs and hypercoagulability screening panel. CASE REPORT We describe a right-handed patient who lifts weights for exercise, who presented with pulmonary infarcts and clot in the right superior vena cava/subclavian vein. These were due to a combination of 1) an acquired hypercoagulability from minimal change disease and 2) dynamic anatomic narrowing of the subclavian vein, which is known as Paget-Schroetter syndrome. Despite normal serum levels of antithrombin, protein C and S, his serum albumin was low, which prompted workup for proteinuria. Testing revealed nephrotic range proteinuria as well as dynamic occlusion of the right subclavian vein on magnetic resonance venography only when the patient lifted and externally rotated his arms. CONCLUSIONS This case report highlights the need for a thorough history and physical examination, as well as additional testing in some patients beyond the initial admission laboratory tests and screening panel for hypercoagulability. Tests could include diagnostic imaging testing with provoking maneuvers, which can help elucidate dynamic physiology. Such testing, when appropriate, can help to inform the treatment plan and prevent recurrent thromboses.

References
1.
Barbour S, Greenwald A, Djurdjev O, Levin A, Hladunewich M, Nachman P . Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2011; 81(2):190-5. DOI: 10.1038/ki.2011.312. View

2.
Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S . Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002; 39(3):503-12. DOI: 10.1053/ajkd.2002.31400. View

3.
Lijfering W, Rosendaal F, Cannegieter S . Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol. 2010; 149(6):824-33. DOI: 10.1111/j.1365-2141.2010.08206.x. View

4.
Khor B, Van Cott E . Laboratory evaluation of hypercoagulability. Clin Lab Med. 2009; 29(2):339-66. DOI: 10.1016/j.cll.2009.03.002. View

5.
Deitcher S, Gomes M . Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med. 2003; 8(1):33-46. DOI: 10.1191/1358863x03vm461ra. View